Conference Proceedings

Abstract 1443: CHKing melanoma: CHK1 inhibitor low dose hydroxyurea triggers immunogenic cell death and immunostimulatory cytokine expression to drive an anti-tumor immune response

Brian G Gabrielli, Martina Proctor, Jazmina Gonzalez Cruz, Bijun Zeng, Riccardo Dolcetti, Colm Keane, Nikolas Haass, James Wells

Experimental and Molecular Therapeutics | American Association for Cancer Research | Published : 2021